IUNIK
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
IUNIK - overview
Location
Seoul, -, South Korea
Primary Industry
Consumer Products
About
IUNIK, based in South Korea, is a skincare company specializing in dermatological cosmetics tailored for sensitive skin, providing innovative solutions that address various skin concerns. IUNIK is a South Korean skincare brand that focuses on dermatological cosmetics for sensitive skin. Founded in Seoul, the company has developed products that prioritize safety and efficacy. The founder's background includes experience in the beauty industry, although specific details about their history or previous ventures are not disclosed.
IUNIK has received funding through multiple rounds, demonstrating its growth potential in the competitive skincare market. IUNIK specializes in dermatological cosmetics designed for sensitive skin, offering a comprehensive range of skincare solutions tailored to various skin concerns such as acne, dryness, oiliness, and combination skin. Their core products include the Beta-Glucan Barrier Sunscreen, Centella Relief Toner, and Propolis Vitamin Synergy Serum, all aimed at enhancing skin health by addressing issues like hydration and pigmentation. The brand targets individuals and families with sensitive skin, ensuring their products are safe for all ages and accessible through various online platforms and retail channels.
IUNIK's revenue model is characterized by direct-to-consumer sales, primarily through their online platform, which features a customer loyalty program incentivizing repeat purchases. Products are sold individually or in bundled sets, catering to diverse customer needs. Their pricing strategy is competitive, with flagship items like the Centella Relief Cream and Beta-Glucan Power Moisture Serum positioned to attract a wide customer base, reflecting a commitment to quality and affordability. IUNIK plans to expand its product line, with new formulations targeting additional skin concerns set to launch in the next year.
The company aims to enter new international markets, specifically targeting regions in North America and Europe by the end of 2024. Recent funding will be utilized to support these expansion efforts and enhance product development, ensuring IUNIK can leverage its market position effectively.
Primary Industry
Consumer Products
Sub Industries
Consumer Products, Beauty & Hygiene
Website
www.iunik.co.kr/
Verticals
E-commerce, Manufacturing
Total Amount Raised
Subscriber access only
IUNIK - financials
| Fiscal Year Ended | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|
| Revenue (USD) | 4,977,154,000 | 7,672,479,000 | - | - | - |
| % Revenue Growth (YoY) | - | 54.2% | - | - | - |
| EBITDA (USD) | - | - | - | - | - |
| Operating Income (USD) | 1,228,495,000 | 1,620,585,000 | - | - | - |
| Operating Margin | 24.7% | 21.1% | - | - | - |
| % EBITDA Margin | - | - | - | - | - |
| NET Income (USD) | 1,018,594,000 | 1,394,087,000 | - | - | - |
| % Net Margin | 20.5% | 18.2% | - | - | - |

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.